These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33479057)

  • 1. Impaired Activated/Memory Regulatory T Cell Clonal Expansion Instigates Diabetes in NOD Mice.
    Mhanna V; Fourcade G; Barennes P; Quiniou V; Pham HP; Ritvo PG; Brimaud F; Gouritin B; Churlaud G; Six A; Mariotti-Ferrandiz E; Klatzmann D
    Diabetes; 2021 Apr; 70(4):976-985. PubMed ID: 33479057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR sequences and tissue distribution discriminate the subsets of naïve and activated/memory Treg cells in mice.
    Bergot AS; Chaara W; Ruggiero E; Mariotti-Ferrandiz E; Dulauroy S; Schmidt M; von Kalle C; Six A; Klatzmann D
    Eur J Immunol; 2015 May; 45(5):1524-34. PubMed ID: 25726757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.
    Grinberg-Bleyer Y; Saadoun D; Baeyens A; Billiard F; Goldstein JD; Grégoire S; Martin GH; Elhage R; Derian N; Carpentier W; Marodon G; Klatzmann D; Piaggio E; Salomon BL
    J Clin Invest; 2010 Dec; 120(12):4558-68. PubMed ID: 21099113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
    Sgouroudis E; Albanese A; Piccirillo CA
    J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput sequencing reveals restricted TCR Vβ usage and public TCRβ clonotypes among pancreatic lymph node memory CD4(+) T cells and their involvement in autoimmune diabetes.
    Marrero I; Aguilera C; Hamm DE; Quinn A; Kumar V
    Mol Immunol; 2016 Jun; 74():82-95. PubMed ID: 27161799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
    Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
    Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revealing the specificity of regulatory T cells in murine autoimmune diabetes.
    Spence A; Purtha W; Tam J; Dong S; Kim Y; Ju CH; Sterling T; Nakayama M; Robinson WH; Bluestone JA; Anderson MS; Tang Q
    Proc Natl Acad Sci U S A; 2018 May; 115(20):5265-5270. PubMed ID: 29712852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.
    Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Thymic Output of Effector CD4
    Zhao Y; Alard P; Kosiewicz MM
    J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganglioside GM1 deficiency in effector T cells from NOD mice induces resistance to regulatory T-cell suppression.
    Wu G; Lu ZH; Gabius HJ; Ledeen RW; Bleich D
    Diabetes; 2011 Sep; 60(9):2341-9. PubMed ID: 21788572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
    Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
    PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Following the fate of one insulin-reactive CD4 T cell: conversion into Teffs and Tregs in the periphery controls diabetes in NOD mice.
    Fousteri G; Jasinski J; Dave A; Nakayama M; Pagni P; Lambolez F; Juntti T; Sarikonda G; Cheng Y; Croft M; Cheroutre H; Eisenbarth G; von Herrath M
    Diabetes; 2012 May; 61(5):1169-79. PubMed ID: 22403296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in T regulatory cells between mouse strains frequently used in immunological research: Treg cell quantities and subpopulations in NOD, B6 and BALB/c mice.
    Godoy GJ; Paira DA; Olivera C; Breser ML; Sanchez LR; Motrich RD; Rivero VE
    Immunol Lett; 2020 Jul; 223():17-25. PubMed ID: 32330480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells.
    Ferreira C; Singh Y; Furmanski AL; Wong FS; Garden OA; Dyson J
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8320-5. PubMed ID: 19359477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice.
    Presa M; Chen YG; Grier AE; Leiter EH; Brehm MA; Greiner DL; Shultz LD; Serreze DV
    J Immunol; 2015 Oct; 195(7):3011-9. PubMed ID: 26283479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.
    Jaberi-Douraki M; Pietropaolo M; Khadra A
    J Theor Biol; 2015 Oct; 383():93-105. PubMed ID: 26271890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells.
    Flores RR; Zhou L; Robbins PD
    Gene Ther; 2014 Aug; 21(8):715-22. PubMed ID: 24849041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of T-cell-specific Smad4 deficiency on the development of autoimmune diabetes in NOD mice.
    Kim D; Lee SM; Jun HS
    Immunol Cell Biol; 2017 Mar; 95(3):287-296. PubMed ID: 27686408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.